U.S. Epigenetics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits), By Technology (DNA Methylation, Histone Methylation), By Application (Oncology, Non-oncology), By End-use, And Segment Forecasts, 2024 - 2030

Market Segmentation

• U.S. Epigenetics, Product Outlook (Revenue in USD Million, 2018 - 2030)
  • Reagents
  • Kits
    • ChIP Sequencing Kit
    • Whole Genomic Amplification Kit
    • Bisulfite Conversion Kit
    • RNA Sequencing Kit
    • Others
  • Instruments
  • Enzymes
  • Services
• U.S. Epigenetics, Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Non - coding RNA
  • MicroRNA Modification
  • Chromatin Structures
• U.S. Epigenetics, Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non - oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Others
• U.S. Epigenetics, End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Country market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Country market size and forecast for application segments up to 2030
• Company financial performance